undamentalytics Newsletter
Sign in

Bruker Corp balance sheet

At the end of fiscal 2025, Bruker Corp had total assets of $6.24bn, total liabilities of $3.73bn and shareholders' equity of $2.46bn. It held $299m in cash against $1.87bn of debt: net debt of $1.57bn.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents2072302463114393202673423253226786821,068646488183299185
Receivables—233283289308293235244319357362335417473492566545546
Inventory—5115766125904774224404865105776927108009681,0681,0951,120
Total current assets—1,0511,1941,3101,4321,3661,2321,2761,3591,3041,7961,9252,4722,1132,1642,0532,2132,225
Goodwill48981001161271281311311702762933203404585831,5071,5481,430
Total assets—1,5501,7111,8561,9881,8651,7301,8081,9492,1292,7723,0493,6503,6124,2505,8076,2416,053
Accounts payable—6472707576728691105118135147178203234216200
Deferred revenue (current)—70838388897776112124138189198218400438441445
Total current liabilities—8327566826495835555255255996467929399141,2021,2811,2791,205
Short-term debt—186————————————————
Long-term debt—3013033373553552653924163238138421,2221,2011,1602,0621,8531,815
Total debt04873033373553552664124163418138451,3341,2191,2822,0941,8691,825
Total liabilities—————————————2,4802,8373,9923,731—
Shareholders' equity4195256227078467667266867258979079611,0711,1141,3771,7812,4572,400
Net debt (negative = net cash)−2072565727−8436−16991191351632665747931,9111,5701,640
Shares outstanding—165m166m167m168m169m165m160m156m157m154m152m151m147m145m152m152m152m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BRKR vs CRLBRKR vs MTDBRKR vs MEDP

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Bruker Corp's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Bruker Corp.